Eli Lilly vows to extend public&s grant access globally

Share this content:
Eli Lilly, the first drug company to make data on its US educational grants accessible to the public, vowed to extend the policy globally by 2008. Meanwhile, it published its second full quarter of grants online.

Share this content:
Scroll down to see the next article